Investtech.com

Stocks

The table gives an overview of all stocks, alphabetically sorted.
 A-Mark Precious Metals, Inc. AMRK Feb 23, 2017 19.88 +0.76   
 A. Schulman SHLM Feb 23, 2017 33.95 -1.16   
 Aaon Inc AAON Feb 23, 2017 31.95 -7.12   
 Aastrom Biosciences ASTM Feb 23, 2017 2.77 0.00   
 Abaxis Inc ABAX Feb 23, 2017 49.26 -1.08   
 Abengoa S.A. ABGB Feb 23, 2017 1.02 0.00   
 Abeona Therapeutics Inc. ABEOW Feb 23, 2017 3.05 -4.69   
 Abeona Therapeutics Inc. ABEO Feb 23, 2017 5.00 -1.96   
 Ability Inc. ABIL Feb 23, 2017 2.80 -3.18   
 Abiomed ABMD Feb 23, 2017 116.89 -0.09   
 Abraxas Petroleum Corp AXAS Feb 23, 2017 2.21 -1.34   
 AC Asia Ex Japan Smallcap MSCI Ishares AXJS Feb 23, 2017 52.38 0.00   
 AC Asia Information Tech MSCI Ishares AAIT Feb 23, 2017 30.53 0.00   
 AC Immune SA ACIU Feb 23, 2017 12.32 +0.16   
 Acacia Communications, Inc. ACIA Feb 23, 2017 63.43 +1.94   
 Acacia Research Corp ACTG Feb 23, 2017 5.70 -0.87   
 Acadia Healthcare Company Inc ACHC Feb 23, 2017 43.24 +1.41   
 Acadia Pharmaceuticals Inc ACAD Feb 23, 2017 39.56 +1.07   
 Acasti Pharma Inc ACST Feb 23, 2017 1.23 -3.91   
 Accelerate Diagnostics Inc AXDX Feb 23, 2017 24.75 +1.23   
 Acceleron Pharma Inc XLRN Feb 23, 2017 25.20 -1.06   
 Accelrys Inc ACCL Feb 23, 2017 12.51 0.00   
 Access National Corp ANCX Feb 23, 2017 27.82 +0.22   
 Accuray Incorporated ARAY Feb 23, 2017 5.42 0.00   
 Acelrx Pharmaceuticals ACRX Feb 23, 2017 3.10 0.00   
 Aceto Corp ACET Feb 23, 2017 15.45 +0.78   
 Achaogen, Inc. AKAO Feb 23, 2017 23.11 -2.16   
 Achillion Pharmaceuticals ACHN Feb 23, 2017 4.24 +0.95   
 Aci Worldwide ACIW Feb 23, 2017 20.21 +0.65   
 Aclaris Therapeutics, Inc. ACRS Feb 23, 2017 29.52 +8.57   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK